Industry-best custom affinity resin development from Repligen offers unparalleled ligand diversity, process development and proven success across a broad array of biomolecules.
Single-use chromatography systems from Repligen solve the yield, shear, and separation challenges of traditional systems, through expert engineering and technological innovation of both hardware and flow path.
Repligen is now the only supplier with column packing capabilities on two continents with the new OPUS® Manufacturing Center of Excellence in Breda, The Netherlands.
Repligen Breda simplifies European supply chain logistics by enabling regional column packing. Global customers realize benefits of expanded manufacturing capacity for OPUS® Columns.
Designed to meet the rigors of regulatory GMP requirements, the new CTech FlowVPX offers reliable real-time results with integrated ease for concentration measurements during every stage of the downstream GMP process.
Designed for simplicity and engineered for precision, the new XCell™ Lab System integrates a modernized controller, intuitive software, and monitoring devices.
Repligen introduces novel affinity resin for the purification of the SARS CoV-2 Spike Protein for vaccine development and manufacturing. NGL COVID-19 Spike Protein Affinity Resin binds the SARS-CoV-2 Spike Protein receptor binding domain (RBD) to yield exceptional purity in a single chromatography step. The resin is available in off-the shelf, pre-packed and pre-qualified OPUS® Columns for rapid implementation as well as in loose resin formats.